(Q37650448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001631%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

review article

1 reference

title

Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001631%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001631%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

John B Porter

series ordinal

1

1 reference

21 August 2017

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001631%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001631%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

33 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001631%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

S37-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001631%20AND%20SRC:MED&resulttype=core&format=json

Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Hepatocellular carcinoma in the thalassaemia syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Hepatic iron concentration and total body iron stores in thalassemia major.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Progression of iron overload in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Circumstances of death in adult sickle cell disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Concepts and goals in the management of transfusional iron overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Hepatic lipid peroxidation in vivo in rats with chronic iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Alterations in the structure, physicochemical properties, and pH of hepatocyte lysosomes in experimental iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Iron toxicity and oxygen radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Interfering RNA-mediated purine analog resistance for in vitro and in vivo cell selection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Iron regulation and erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Liver iron concentrations and urinary hepcidin in beta-thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Iron responses in hepatic, intestinal and macrophage/monocyte cell lines under different culture conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

Use of iron chelators in preventing hydroxyl radical damage: adult respiratory distress syndrome as an experimental model for the pathophysiology and treatment of oxygen-radical-mediated tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03630260903346627

10.3109/03630260903346627

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20001631%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference